All Biotech News

List of articles in category All Biotech News
Title	Published Date
Emperra Partners with the Federal Initiative "German Accelerator Life Sciences" to Expand to US	06/03/2016
Agendia Appoints Dr. Gabriel Hortobagyi as Chairman to their Medical Advisory Board	06/01/2016
Merus N.V. Signs Commercial Multi-Product License for ProBioGen’s GlymaxX® ADCC Enhancement Technology	06/01/2016
ChemConnection and Cristal Therapeutics Announce Successful GMP Production of CriPec® Docetaxel for Phase 1/2a Clinical Trials	06/01/2016
Clinical Study in UK to Evaluate ReGenerCell™ for Diabetic Foot Ulcer Treatment	05/31/2016
Evercyte and VTU Technology Collaborate On Development of Recombinant Media Supplements	05/24/2016
ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics	05/18/2016
Ganymed to Present Exciting Phase II Clinical Data for IMAB362 in Gastroesophageal Cancer at ASCO 2016 Annual Meeting	05/17/2016
Vetter is a Winner of the AbbVie TRIUMPH AWARD	05/11/2016
LDC and Boehringer Ingelheim Join Forces to Discover a Novel Approach for the Treatment of Schizophrenia	05/11/2016
EMA/CHMP Adopts Positive Opinion for ITM´s EndolucinBeta®	05/10/2016
RedHill Biopharma Announces National Cancer Institute Grant Supporting YELIVA™ Phase II Hepatocellular Carcinoma Study	05/05/2016
Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference	05/04/2016
Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies	05/03/2016
CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders	04/29/2016
Cristal Therapeutics Announces Appointment of Edwin Klumper as Chief Medical Officer	04/29/2016
VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration	04/27/2016
ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology	04/19/2016
Agendia’s MammaPrint® First and Only Genomic Assay to Receive Level 1A Clinical Utility Evidence for Chemotherapy Benefit in Early Breast Cancer Patients	04/19/2016
RedHill Biopharma Announces Positive FDA Meeting on RHB-105 Path to Approval and Planned Confirmatory Phase III Study for H. pylori Infection	04/18/2016
Selvita Files IND Application for its Novel, Dual PIM/FLT3 Inhibitor in AML	04/18/2016
MINDACT Trial Findings on Agendia’s MammaPrint to be Presented during AACR Annual Meeting 2016	04/15/2016
Apollo Therapeutics: Dr Richard Butt Appointed CEO	04/14/2016
Tech Transfer: 9th BioVaria to Take Place in Munich on 17 May 2016	04/13/2016
Susanne Resatz, President of Vetter Development Services USA, Inc. is Elected to the Board of Directors of the German American Chamber of Commerce® of the Midwest, Inc.	04/12/2016
RedHill Biopharma Initiates Phase II Study of BEKINDA™ for Irritable Bowel Syndrome	04/12/2016
Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M	04/12/2016
4th Laupheim Biotech Days to Take Place June 13 to 14, 2016	04/11/2016
Adherium Appoints Senior Executive to Lead Market Expansion and Establishes European Operations	04/04/2016
RedHill Biopharma Announces Interim Results from Phase IIa Proof-of-Concept Study Supporting Therapeutic Potential of RHB-104 in Multiple Sclerosis	04/01/2016

Page 48 of 88